Dr. Contreras is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2050 Kenny Rd
4th Floor
Columbus, OH 43221Phone+1 614-293-7171Fax+1 614-293-3465
Summary
- Dr. Carlo M. Contreras completed his Surgical Oncology training at the M.D. Anderson Cancer Center in Houston, TX. There, his focus was on the most effective approaches for complex oncologic cases. As a member of the OSU Surgical Oncology faculty he cares for patients with a variety of malignancies including melanoma, Merkel cell carcinoma and other skin/soft tissue tumors. He promotes a patient-centered approach, and feels that effective communication is paramount in the multidisciplinary care of his patients. Dr. Contreras is pleased to offer a broad range of oncologic therapies, including minimally invasive and robotic approaches.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2008 - 2010
- University of Wisconsin Hospitals and ClinicsResidency, Surgery, 2003 - 2008
- Northwestern University The Feinberg School of MedicineClass of 2003
Certifications & Licensure
- OH State Medical License 2019 - 2025
- AL State Medical License 2010 - 2019
- TX State Medical License 2008 - 2012
- WI State Medical License 2004 - 2011
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons, 2013
- Lifetime Member Alpha Omega Alpha, 2003
- Fellow American College of Surgeons
Clinical Trials
- Collection and Storage of Tissue and Blood Samples From Patients With Cancer Start of enrollment: 2015 May 19
- Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma Start of enrollment: 2021 Oct 20
- EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers Start of enrollment: 2023 Dec 19
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Achieving Adherence With NCCN Guidelines for Nonmelanoma Skin Cancer Regarding Peripheral and Deep En Face Margin Assessment (PDEMA).Yaohui G Xu, Young Lim, Jeremy S Bordeaux, Sumaira Z Aasi, Murad Alam
Journal of the National Comprehensive Cancer Network. 2024-11-01 - Metastatic Adrenocortical Carcinoma to the Skin: A Case Report and Review of This Unusual Neoplasm.Efrain Lee-Diaz, Carlo Contreras, Jose A Plaza
The American Journal of Dermatopathology. 2024-10-01 - Adjuvant PD-1-based therapies for high-risk resected melanomas are here to stay.Tarek Haykal, Carlo Contreras
American Journal of Surgery. 2024-09-01
Journal Articles
- Adjuvant trials for pancreatic cancer: where are we going and what is needed?Suzanne Russo, Roger Ove, Carlo Contreras & Muhammad Wasif Saif, Clinical Investigation, 5/2011
Authored Content
- A World of Global SurgeryMay 2019
Press Mentions
- Custom Smartwatch Could Detect Early Signs of Conditions That Impact Millions of Cancer SurvivorsOctober 6th, 2024
- Sedentary Lifestyle Could Increase Risk of Colorectal Cancer in Young WomenFebruary 5th, 2019
- Four in U.K. Develop Cancer After Organ Transplant. Is There Cause for Worry?September 29th, 2018
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Spanish
External Links
- Faculty Profilehttps://cancer.osu.edu/find-a-doctor/search-physician-directory/carlo-contreras
- Doxy.mehttps://doxy.me/melanoma
- HealthTap linkhttps://www.healthtap.com/#experts/10040183/about
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: